Bioventus/$BVS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bioventus
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Ticker
$BVS
Sector
Primary listing
Employees
930
Headquarters
Website
Bioventus Metrics
BasicAdvanced
$501M
48.71
$0.15
0.80
-
Price and volume
Market cap
$501M
Beta
0.8
52-week high
$12.24
52-week low
$5.81
Average daily volume
305K
Financial strength
Current ratio
1.737
Quick ratio
1.067
Long term debt to equity
157.058
Total debt to equity
157.772
Interest coverage (TTM)
1.61%
Profitability
EBITDA (TTM)
65.965
Gross margin (TTM)
67.76%
Net profit margin (TTM)
1.80%
Operating margin (TTM)
8.63%
Effective tax rate (TTM)
14.66%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
5.30%
Return on equity (TTM)
6.38%
Valuation
Price to earnings (TTM)
48.705
Price to revenue (TTM)
0.879
Price to book
3.02
Price to tangible book (TTM)
-2.29
Price to free cash flow (TTM)
9.265
Free cash flow yield (TTM)
10.79%
Free cash flow per share (TTM)
0.807
Growth
Revenue change (TTM)
1.58%
Earnings per share change (TTM)
-123.35%
3-year revenue growth (CAGR)
2.95%
3-year earnings per share growth (CAGR)
-58.30%
What the Analysts think about Bioventus
Analyst ratings (Buy, Hold, Sell) for Bioventus stock.
Bioventus Financial Performance
Revenues and expenses
Bioventus Earnings Performance
Company profitability
Bioventus News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bioventus stock?
Bioventus (BVS) has a market cap of $501M as of November 07, 2025.
What is the P/E ratio for Bioventus stock?
The price to earnings (P/E) ratio for Bioventus (BVS) stock is 48.71 as of November 07, 2025.
Does Bioventus stock pay dividends?
No, Bioventus (BVS) stock does not pay dividends to its shareholders as of November 07, 2025.
When is the next Bioventus dividend payment date?
Bioventus (BVS) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioventus?
Bioventus (BVS) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.